as on March 4, 2026 at 6:11 am IST
Day's Low
Day's High
1.70%
Downside
1.94%
Upside
52 Week's Low
52 Week's High
48.54%
Downside
83.25%
Upside
Check Aquestive Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$488.0M
EPS (TTM)
-0.59
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-15.58
Industry PE ratio
0PEG Ratio
0EBITDA
-55.2M
Revenue (TTM)
43.4M
Profit Margin
-158.95%
Return On Equity TTM
0.00%
Track how Aquestive Therapeutics Inc P/E has moved over time to understand its valuation trends.
Aquestive Therapeutics Inc in the last 5 years
Lowest (-9.82x)
June 30, 2024
Industry (0.00x)
March 3, 2026
Today (-15.58x)
March 3, 2026
Highest (-0.82x)
December 31, 2022
Today’s Price to Earnings Ratio: -15.58x
Compare market cap, revenue, PE, and other key metrics of Aquestive Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $488.0M | -10.99% | -15.58 | -158.95% | |
| BUY | $23.2B | NA | 19.09 | 41.94% | |
| HOLD | $17.2B | 13.11% | -21.95 | -24.58% | |
| BUY | $49.3B | NA | 22.14 | 15.11% | |
| BUY | $57.8B | -13.64% | 21.78 | 28.24% |
The Aquestive Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Aquestive Therapeutics Inc investment value today
Current value as on today
₹1,60,976
Returns
₹60,976
(+60.98%)
Returns from Aquestive Therapeutics Inc Stock
₹55,472 (+55.47%)
Dollar Returns*
₹5,505 (+5.5%)
Based on 14 analysts
92.86%
Buy
7.14%
Hold
0.00%
Sell
Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Aquestive Therapeutics Inc. Average target price of $9.22
Get share price movements and forecasts by analysts on Aquestive Therapeutics Inc.
What analysts predicted
55.31%UPSIDE
Target Price
$9.22
Current Price
$4.12
Analyzed by
14 Analysts
Target
$9.22
Aquestive Therapeutics Inc target price $9.22, a slight upside of 55.31% compared to current price of $4.12. According to 14 analysts rating.
Search interest for Aquestive Therapeutics Inc Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 08 October
Wed, 05:20 PM
-Aquestive Therapeutics secures two new U.S. patents for Anaphylm, extending protection until 2037, potentially transforming anaphylaxis treatment.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 8.72M → 12.80M (in $), with an average increase of 17.4% per quarter
Best in 3 Years
![]()
In the last 3 years, AQST has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 3 years, AQST stock has moved up by 433.2%
Against Peers
![]()
In the last 1 year, Viatris Inc. has given 68.3% return, outperforming this stock by 9.4%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -13.54M → -15.44M (in $), with an average decrease of 14.0% per quarter
| Organisation | Aquestive Therapeutics Inc |
| Headquarters | 30 Technology Drive, Warren, NJ, United States, 07059 |
| Industry | Health Technology |
| CEO | Mr. Daniel Barber |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Sherry Korczynski | Chief Commercial Officer |
Dr. Melina T. Cioffi Pharm.D. | Senior Vice President of Regulatory Affairs |
Mr. Daniel Barber | CEO, President & Director |
Ms. Lori J. Braender BSBA, Esq., J.D. | Chief Legal Officer, Chief Compliance Officer & Secretary |
Mr. A. Ernest Toth Jr. | Chief Financial Officer |
Dr. Matthew Greenhawt B.Sc., M.B.A., M.D. | Chief Medical Officer |
Dr. Matthew William Davis M.D., R.Ph. | Chief Development Officer |
Ms. Cassie Jung | Chief Operating Officer |
Mr. Peter E. Boyd | Senior Vice President of Information Technology & Chief People Officer |
Dr. Gary H. Slatko M.D., MBA | Interim Chief Medical Officer |
Aquestive Therapeutics Inc share price today is $4.12 as on . Aquestive Therapeutics Inc share today touched a day high of $4.2 and a low of $4.05.
Aquestive Therapeutics Inc share touched a 52 week high of $7.55 on and a 52 week low of $2.12 on . Aquestive Therapeutics Inc stock price today i.e. is trending at $4.12,which is 45.43% down from its 52 week high and 94.34% up from its 52 week low.
Aquestive Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Aquestive Therapeutics Inc (AQST) shares with as little as ₹92.074 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in Aquestive Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aquestive Therapeutics Inc share’s latest price of $4.12 as on March 4, 2026 at 12:41 am IST, you will get 2.4272 shares of Aquestive Therapeutics Inc. Learn more about
fractional shares .
Aquestive Therapeutics Inc stock has given -10.99% share price returns and 25.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?